Home

Clinical Trials / Essais cliniques

Canada is widely known for its extensive clinical research about skin disease. There are often clinical trials underway in your area and you may benefit from the experimental medication or treatments they include. Click the links below to learn more about clinical trials happening across Canada. Select the skin disease you're interested in from the left menu and the province or territory from the right menu to learn about clinical trials being conducted in your area. Click "Submit". Then, click on the name of the clinical trial to read about it:
Skin DiseaseProvince / Territory
Trialsort iconSkin DiseaseProvince & Territory
Efficacy of Algae Formulations on People with PsoriasisPsoriasisManitoba
Open Label Study of Adalimumab in Subjects Who Have a Sub-Optimal Response to Systemic Therapy or PhototherapyPsoriasisQuebec
Safety and Efficacy of Combining nbUVB to Etanercept in PatientsPsoriasisQuebec
ChangE From Any Systemic psoriasiS therapY to Raptiva (EASY)PsoriasisOntario
Efficacy and Safety of Calcipotriol Plus Hydrocortisone Ointment Compared With Tacalcitol Ointment in Patients With Psoriasis onPsoriasisOntario
AMG 714 20060349 Multiple Dose Study in Moderate to Severe Psoriasis SubjectsPsoriasisOntario
Assessment and Tracking of Long-Term Alefacept Safety (ATLAS)PsoriasisManitoba
Assessment and Tracking of Long-Term Alefacept Safety (ATLAS)PsoriasisNew Brunswick
Assessment and Tracking of Long-Term Alefacept Safety (ATLAS)PsoriasisNewfoundland and Labrador
Assessment and Tracking of Long-Term Alefacept Safety (ATLAS)PsoriasisOntario
Assessment and Tracking of Long-Term Alefacept Safety (ATLAS)PsoriasisQuebec
Assessment and Tracking of Long-Term Alefacept Safety (ATLAS)PsoriasisSaskatchewan
PSUNRISE - Prospective Study Using Remicade in Psoriasis Patients With an Inadequate Response to EtanerceptPsoriasisBritish Columbia
PSUNRISE - Prospective Study Using Remicade in Psoriasis Patients With an Inadequate Response to EtanerceptPsoriasisNew Brunswick
PSUNRISE - Prospective Study Using Remicade in Psoriasis Patients With an Inadequate Response to EtanerceptPsoriasisOntario
123456789next ›last »

Contact Information:

Canadian Skin Patient Alliance
2446 Bank Street, Suite 383
Ottawa, Ontario
K1V 1A8
 

Christine Jackson, Executive Director
phone: 613-422-4265
fax: 613-422- 4267
 

pageTracker._trackPageview();